Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | +1.33% | -7.69% | -2.15% |
Jun. 07 | Top Premarket Gainers | MT |
Jun. 05 | VYNE Therapeutics Inc. Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibitor VYN201 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.15% | 32.69M | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Menlo Therapeutics Inc. Announces Board Changes